Yeh‐Fong Chen

1.3k total citations
17 papers, 1.0k citations indexed

About

Yeh‐Fong Chen is a scholar working on Statistics and Probability, Pharmacology and Economics and Econometrics. According to data from OpenAlex, Yeh‐Fong Chen has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Statistics and Probability, 6 papers in Pharmacology and 5 papers in Economics and Econometrics. Recurrent topics in Yeh‐Fong Chen's work include Statistical Methods in Clinical Trials (8 papers), Treatment of Major Depression (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Yeh‐Fong Chen is often cited by papers focused on Statistical Methods in Clinical Trials (8 papers), Treatment of Major Depression (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Yeh‐Fong Chen collaborates with scholars based in United States, United Kingdom and Canada. Yeh‐Fong Chen's co-authors include John R. Johnson, Rajeshwari Sridhara, Martin H. Cohen, Richard Pazdur, Ni A. Khin, Thomas Laughren, Peiling Yang, Yang Yang, Hung Hung and Yang Yang and has published in prestigious journals such as Clinical Cancer Research, Statistics in Medicine and The Journal of Clinical Psychiatry.

In The Last Decade

Yeh‐Fong Chen

16 papers receiving 1.0k citations

Peers

Countries citing papers authored by Yeh‐Fong Chen

Since Specialization

Citations

This map shows the geographic impact of Yeh‐Fong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeh‐Fong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeh‐Fong Chen more than expected).

Fields of papers citing papers by Yeh‐Fong Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yeh‐Fong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeh‐Fong Chen. The network helps show where Yeh‐Fong Chen may publish in the future.

Co-authorship network of co-authors of Yeh‐Fong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yeh‐Fong Chen. A scholar is included among the top collaborators of Yeh‐Fong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yeh‐Fong Chen. Yeh‐Fong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Challenges and potential strategies utilizing external data for efficacy evaluation in small-sized clinical trials 2022 ·Journal of Biopharmaceutical Statistics ·(unknown), Yeh‐Fong Chen, Min Min, Sara Jiménez	2
2	Consideration of the adaptive randomization allocation ratio in the presence of treatment group heteroscedasticity in clinical trials 2022 ·Journal of Biopharmaceutical Statistics ·(unknown), Yeh‐Fong Chen	0
3	The plan of enrichment designs for dealing with high placebo response 2017 ·Pharmaceutical Statistics ·Xiangmin Zhang, Yeh‐Fong Chen, Roy Tamura	3
4	Unified additional requirement in consideration of regional approval for multiregional clinical trials 2017 ·Journal of Biopharmaceutical Statistics ·Zhaoyang Teng, Yeh‐Fong Chen, Mark Chang	3
5	Clinical endpoints and adaptive clinical trials in precirrhotic nonalcoholic steatohepatitis: Facilitating development approaches for an emerging epidemic 2017 ·Hepatology Communications ·Claudia Filozof, Shein‐Chung Chow, Lara Dimick‐Santos, Yeh‐Fong Chen, (unknown), Barry J. Goldstein, Arun J. Sanyal	48
6	Testing treatment effect in schizophrenia clinical trials with heavy patient dropout using latent class growth mixture models 2016 ·Pharmaceutical Statistics ·Fanhui Kong, Yeh‐Fong Chen	2
7	A small n sequential multiple assignment randomized trial design for use in rare disease research 2015 ·Contemporary Clinical Trials ·Roy Tamura, Jeffrey P. Krischer, Christian Pagnoux, Robert G. Micheletti, Peter C. Grayson, Yeh‐Fong Chen, Peter A. Merkel	27
8	A sequential enriched design for target patient population in psychiatric clinical trials 2014 ·Statistics in Medicine ·Yeh‐Fong Chen, Xiangmin Zhang, Roy Tamura, Chiung M. Chen	10
9	Review of Maintenance Trials for Major Depressive Disorder 2014 ·The Journal of Clinical Psychiatry ·(unknown), Yeh‐Fong Chen, Thomas Laughren, (unknown), (unknown), Paul A. David, Mitchell Mathis, Ellis F. Unger, Peiling Yang, Ni A. Khin	88
10	Exploratory Analyses of Efficacy Data From Schizophrenia Trials in Support of New Drug Applications Submitted to the US Food and Drug Administration 2012 ·The Journal of Clinical Psychiatry ·Ni A. Khin, Yeh‐Fong Chen, Yang Yang, Peiling Yang, Thomas Laughren	63
11	Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications 2011 ·The Journal of Clinical Psychiatry ·Ni A. Khin, Yeh‐Fong Chen, Yang Yang, Peiling Yang, Thomas Laughren	168
12	Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials 2011 ·Contemporary Clinical Trials ·Yeh‐Fong Chen, Yang Yang, Hung Hung, Sue‐Jane Wang	64
13	Dr Khin and Colleagues Reply 2011 ·The Journal of Clinical Psychiatry ·Ni A. Khin, Yeh‐Fong Chen, Yang Yang, Peiling Yang, Thomas Laughren	2
14	Trial design issues and treatment effect modeling in multi‐regional schizophrenia trials 2010 ·Pharmaceutical Statistics ·Yeh‐Fong Chen, (unknown), Ni A. Khin, Hung Hung, Thomas Laughren	38
15	A Bias Correction in Testing Treatment Efficacy Under Informative Dropout in Clinical Trials 2009 ·Journal of Biopharmaceutical Statistics ·Fanhui Kong, Yeh‐Fong Chen, Kun Jin	1
16	FDA Drug Approval Summary: Erlotinib (Tarceva®) Tablets 2005 ·The Oncologist ·Martin H. Cohen, John R. Johnson, Yeh‐Fong Chen, Rajeshwari Sridhara, Richard Pazdur	351
17	Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen 2005 ·Clinical Cancer Research ·John R. Johnson, Martin H. Cohen, Rajeshwari Sridhara, Yeh‐Fong Chen, Gene M. Williams, John Duan, Jogarao Gobburu, Brian Booth, Kimberly Benson, John Leighton, (unknown), (unknown), P. V. Zimmerman, Richard Pazdur	179

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact